AK117/Placebo with Azacitidine
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination With Azacitidine in Patients With Newly Diagnosed Higher-risk Myelodysplastic Syndromes
Arms / Cohorts
Experimental:AK117 (dose 1) in combination with azacitidine
Accepting patients
Experimental:AK117 (dose 2) in combination with azacitidine
Accepting patients
Active Comparator:Placebo in combination with azacitidine
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.